52977-95-4 Usage
Uses
Used in Pharmaceutical Research:
3-(4-Chlorophenyl)-4-hydroxybutyric Acid is used as a research compound for its potential applications in the pharmaceutical industry. As a metabolite of Baclofen, it may have implications in the development of new drugs or therapies.
Used in Chemical Synthesis:
3-(4-Chlorophenyl)-4-hydroxybutyric Acid is used as a chemical intermediate in the synthesis of various compounds. Its unique structure allows it to be a valuable building block for creating new molecules with specific properties.
Used in Analytical Chemistry:
3-(4-Chlorophenyl)-4-hydroxybutyric Acid can be used as a reference material or standard in analytical chemistry. Its distinct chemical properties make it suitable for calibrating instruments and validating analytical methods.
Used in Material Science:
3-(4-Chlorophenyl)-4-hydroxybutyric Acid may have potential applications in material science, where its unique chemical structure could be utilized to develop new materials with specific properties or functions.
Check Digit Verification of cas no
The CAS Registry Mumber 52977-95-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,7 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 52977-95:
(7*5)+(6*2)+(5*9)+(4*7)+(3*7)+(2*9)+(1*5)=164
164 % 10 = 4
So 52977-95-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H11ClO3/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8,12H,5-6H2,(H,13,14)
52977-95-4Relevant academic research and scientific papers
Procopiou, Panayiotis A.,Barrett, Tim N.,Copley, Royston C.B.,Tame, Christopher J.
, p. 1384 - 1393 (2017)
The absolute configuration of two novel αvβ6 integrin inhibitors was established via degradation to the corresponding C3-aryl substituted butyrolactone. The configuration of the resulting lactones was established by asymmetric synthesis using 1,4-addition of arylboronic acids to butenolide, catalysed by bis(norbornadiene)rhodium (I) tetrafluoroborate in the presence of (R)-BINAP, and confirmed by X-ray crystallography. Studies on arylboronic acid conjugate additions to acyclic crotonate esters bearing a γ-oxygen substituent are also reported. Three Rh catalysts were investigated and the one giving the highest enantioselectivity was bis(norbornadiene)rhodium (I) tetrafluoroborate.
